Results 261 to 270 of about 25,392 (338)

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]

open access: yesACS Chem Neurosci
Gregro AR   +24 more
europepmc   +1 more source

Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD study. [PDF]

open access: yesESMO Open
Trotman J   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy